tbuckley/cabot-search huggingface dataset:
Celmod Induced Disruption of Granulopoiesis Continuum Identified Using Humanized Cereblon Mice
Authors: Ajit Dhadve, Neelam Kumari, Amrutha Y, Riddhita Deb, Gobinathan Rengarasu, Ramya V, Swetha Muralidhar, Shwetank Verma, Patrick R Hagner, Sambuddo Mukherjee, Anita K. Gandhi
Journal: Blood (2023)
Incidence and Risk Factors of Veno-Occlusive Disease Are Different in Younger Versus Older Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Curtis Marcoux, Rima M. Saliba, Whitney Wallis, Sajad Khazal, Dristhi Ragoonanan, Gabriela Rondon, Priti Tewari, Uday R. Popat, Betul Oran, Amanda L. Olson, Qaiser Bashir, Muzaffar H. Qazilbash, Amin Alousi, Chitra Hosing, Yago Nieto, Gheath Alatrash, David Marin, Katayoun Rezvani, Issa F. Khouri, Samer A. Srour, Richard E. Champlin, Elizabeth J. Shpall, Partow Kebriaei
Journal: Blood (2023)
Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial
Authors: Xiaohui Suo, Dongmei Wang, Fang Zheng, Suping Zhang, Congcong Zhang, Yinling Li, Rui Shi, Yan Wu, Sisi Yang, Liyun Zhao, Zongjiu Jiao, Jie Liu, Ling Zhang, Ling Li, Zhihua Zhang, Xinxiao Lu, Linyu Yuan, Sifeng Gao, Jilei Zhang, Xingli Zhao, Guanchen Bai, Yingchang Mi, Kaiqi Liu
Journal: Blood (2023)
Phase 1 Trial of Dendritic Cell/AML Fusion Cell Vaccine after Allogeneic Stem Cell Transplant in Acute Myeloid Leukemia
Authors: Jessica Liegel, Giulia Cheloni, Georges Chedid, Genevieve Gerhard, Dimitra Karagkouni, Richard Stone, Robert J. Soiffer, Lina Bisharat, Samprity Ankita, Isabella Saldarriaga, Emma K Logan, Michele Narcis, Jennifer Tichon, Yiwen Liu, Malgorzata McMasters, Juan Carlos Varela, Hassan El Banna, Vincent T. Ho, Rizwan Romee, Donna S. Neuberg, Kathrine S Rallis, Sophia Adamia, Benjamin L. Ebert, Donald Kufe, Ioannis Vlachos, David Avigan, Jacalyn Rosenblatt
Journal: Blood (2023)
Abatacept and Ptcy Based Gvhd Prophylaxis with CNI/Sirolimus for Haploidentical HCT: Donor KLRC2 Genotype Impacts Outcome
Authors: Sarita Rani Jaiswal, Mahak Agarwal, Prakash Baligar, Subhrajit Biswas, Bhudev C Das, Andrea Bacigalupo, Suparno Chakrabarti
Journal: Blood (2023)
A Multicentre, Randomized, Double-Blinded, Phase 2b Study Evaluating the Efficacy and Safety of MaaT033, an Oral, Pooled Microbiome Ecosystem Therapy in Patients Undergoing Allogenic Hematopoietic Cell Transplantation to Improve Overall Survival: The Phoebus Trial
Authors: Florent Malard, Myriam Labopin, Ernst Holler, Joël Doré, Emilie Plantamura, Mohamad Mohty
Journal: Blood (2023)
Poor Hematopoietic Reserve at the Time of CD19 CAR T-Cell Infusion Is Associated with Long Term B-Cell Aplasia
Authors: Grace Johnson, Kedar Patel, Brian Arciola, Ariel Perez Perez, Anthony Wood, Filip Ionescu, Jennifer M Logue, Omar Albanyan, Hassaan Yasin, Christina A Bachmeier, Kayla Reid, Meghan Menges, Salvatore Corallo, Bijal D. Shah, Julio C Chavez, Farhad Khimani, Taiga Nishihori, Rawan Faramand, Hien Liu, Aleksandr Lazaryan, Kai Rejeski, Marion Subklewe, Fabiana Perna, Marco Davila, Rahul Mhaskar, Frederick L. Locke, Michael D. Jain
Journal: Blood (2023)
Effect of Early Cytomegalovirus Reactivation on Relapse in Adult Patients with Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: A Registry Study from the Japan Society for Transplantation and Cellular Therapy (JSTCT)
Authors: Tatsuya Konishi, Kensuke Matsuda, Hidehiro Itonaga, Noriko Doki, Tetsuya Nishida, Ken-Ichi Matsuoka, Takashi Ikeda, Yoshinobu Kanda, Takahiro Fukuda, Junya Kanda, Hirohisa Nakamae, Tatsuo Ichinohe, Yoshiko Atsuta, Ken Ishiyama
Journal: Blood (2023)
Impact of Obesity on Efficacy, Safety, and Expansion Kinetics of Chimeric Antigen Receptor-T (CAR T) Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma (LBCL)
Authors: Anmol Goyal, Sushma Bharadwaj, Dasom Lee, Eric Lau, Mark P. Hamilton, Alexandria Jensen, Bita Sahaf, Shriya Syal, Sunita Patil, Juancarlos E Cancilla, Theresa Latchford, Wen-Kai Weng, Melody Smith, Matthew J. Frank, David B. Miklos, Saurabh Dahiya
Journal: Blood (2023)
The CDK-Inhibitor p27 Kip1 Regulates Fetal Hemoglobin Expression
Authors: Ginette Balbin-Cuesta, Greggory Myers, Claire Kerpet, Beth McGee, Katherine Rybkin, Zesen Lin, Claire Drysdale, Ann Friedman, Sharon A Singh, Lei Yu, Ayse Bilge Ozel, Rami Khoriaty
Journal: Blood (2023)
Long-Term Remissions with MRD-Guided Acalabrutinib, Venetoclax and Obinutuzumab in Relapsed/Refractory CLL: Follow-up Efficacy and Circulating Tumor DNA Analysis of the CLL2-Baag Trial
Authors: Moritz Furstenau, Adam Giza, Anna-Maria Fink, Sandra Robrecht, Jonathan Weiss, Fanni Kleinert, Christof Schneider, Eugen Tausch, Kirsten Fischer, Petra Langerbeins, Othman Al-Sawaf, Johannes Schetelig, Peter Dreger, Sebastian Böttcher, Karl-Anton Kreuzer, Matthias Ritgen, Anke Schilhabel, Monika Brüggemann, Stephan Stilgenbauer, Barbara F. Eichhorst, Michael Hallek, Paula Cramer
Journal: Blood (2023)
Translation Inhibition through eIF4A1 Targeting in Multiple Myeloma Is a Promising Therapeutic Strategy
Authors: Laure Dutrieux, Elle Loughran, Armelle Choquet, Hélène Herault, Antoine Guillemin, Nicolas Robert, Guilhem Requirand, Guillaume Cartron, Laure Vincent, Charles Herbaux, Eric Rivals, Alexandre David, Jerome Moreaux
Journal: Blood (2023)
Incidence of Second Primary Malignancies in Medicare-Insured Patients in the US with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Authors: Sikander Ailawadhi, Thomas Delea, Aaron Moynahan, Wenzhen Ge, Christian Hampp, Alexi Archambault, Ning Wu, Karen Rodriguez Lorenc, Irene Noguera-Troise, Glenn S. Kroog, Yariv Houvras, Qiufei Ma
Journal: Blood (2023)
A Phase 1 First-in-Human Monotherapy Study of F182112, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed or Refractory Multiple Myeloma
Authors: Mingyuan Sun, Junyuan Qi, Lugui Qiu, Jie Jin, Xin Li, Yongqiang Wei, Guimin Zhang, Xue Liu, Shaohong Yin
Journal: Blood (2023)
The Roles of Immune Cells Derived from Clonal Hematopoiesis in Colorectal Cancer Metastasis
Authors: Tran Bich Nguyen, Ai Nhan Thi Le, YuanJiao Duan, Yoshiaki Abe, Yen Nguyen, Mizuho Nakayama, Masanobu Oshima, Yuya Sasaki, Tatsuhiro Sakamoto, Manabu Fujisawa, Shigeru Chiba, Mamiko Sakata-Yanagimoto
Journal: Blood (2023)
Real-World Treatment Patterns Among Patients with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) with TP53 Mutation in the United States (US)
Authors: Rebecca Bystrom, Laura L. Fernandes, Joseph Wynne, Dianne Pulte, Eric Hansen, Andrew J. Belli, Anna Barcellos, Christina M. Zettler, Jonathon Vallejo, Kelly Norsworthy, Angelo De Claro, Catherine Lerro, Marc R Theoret, Ching-Kun Wang, Donna Rivera
Journal: Blood (2023)
Fms-like Tyrosine Kinase 3 Ligand Kinetic Profile Is the Strongest Factor Predicting Refractoriness after Induction and Event-Free Survival in Adults with AML: A Filo Prospective Multicentric Study
Authors: Pierre Peterlin, Joëlle Gaschet, Sarah Bertoli, Marc Bernard, Martin Carre, Pierre-Yves Dumas, Mathilde Hunault, Amine Belhabri, Anne Banos, Caroline Bonmati, Emmanuelle Tavernier, Gaelle Guillerm, Sarah Bonnet, Justine Decroocq, Alain Saad, Mario Ojeda-Uribe, Romain Guieze, Tony Marchand, Christian Recher, Alice Garnier, Marie-Anne Vibet, Patrice Chevallier
Journal: Blood (2023)
Comprehensive Characterization of Coagulation Parameters in Venous Malformations
Authors: Valentina Restrepo, Alexander B Pine, Ayesha Butt, Eric Y Chang, Noffar Bar, Audrey Baluha, Andrea Brooks, Giavanna Chirico, Jeffrey Curran, Anne Dumont, Pauline Obura-Wilkes, Henry M Rinder, Christopher Tormey, Naiem Nassiri, Alfred I Lee, Stephanie Prozora
Journal: Blood (2023)
Analysis of Tagraxofusp Activity in AML-Pdc As a Single Agent and in Combination with BCL2 Inhibitors
Authors: Morgane Boichut, Margaux Poussard, Imane Belakri, Xavier Roussel, Sabeha Biichle, Maxime Fredon, Florian Renosi, Eric Deconinck, Christopher Brooks, Francine Garnache Ottou, Fanny Delettre
Journal: Blood (2023)
Idecabtagene Vicleucel (ide-cel) Versus Standard (std) Regimens in Patients (pts) with Triple-Class-Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): Updated Analysis from KarMMa-3
Authors: Paula Rodríguez Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina K. Patel, Michele Cavo, Ajay K. Nooka, Salomon Manier, Natalie S. Callander, Luciano Costa, Ravi Vij, Nizar J Bahlis, Philippe Moreau, Scott R. Solomon, Ingerid Weum Abrahamsen, Rachid Baz, Annemiek Broijl, Christine Chen, Sundar Jagannath, Noopur S. Raje, Christof Scheid, Michel Delforge, Reuben Benjamin, Thomas Pabst, Shinsuke Iida, Jesus G. Berdeja, Anna Truppel-Hartmann, Rashmi Bhatnagar, Fan Wu, Julia Piasecki, Laurie Eliason, Devender Dhanda, Jasper Felten, Andrea Caia, Mark Cook, Mihaela Popa-McKiver, Sergio A. Giralt
Journal: Blood (2023)
Resistance to CD38 Antigen Targeted Therapy in Multiple Myeloma May Result from Underrecognized Chromosome 4 Gene Deletions
Authors: Andrew J Portuguese, Min Fang, Sherilyn A. Tuazon, Margot Pont, Xiaoyu Qu, Carolyn Shasha, Melissa L Comstock, Justina Lyons, Gabriel Cole, Evan W. Newell, Emily Glynn, Lorinda Soma, Damian J Green
Journal: Blood (2023)
Parallel Genomic Analysis from Paired Bone Marrow and Peripheral Blood Samples of 200 Cytopenic Patients
Authors: Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann, Isolde Summerer, Henning Ruge, Constance Regina Baer, Wolfgang Kern, Claudia Haferlach
Journal: Blood (2023)
Comparing Racial Disparities of Cardiovascular Manifestations in Sickle Cell Trait
Authors: Praneeth Reddy Keesari, Charan Thej Reddy Vegivinti, Ahmad Mustafa, Suzanne El-Sayegh, Hasnain Chaudhry, Shweta Ravindra Deshpande, Ngowari Pokima, Rajvi Gor, Ugochi Olivia Ogu
Journal: Blood (2023)
Favorable Survival Outcomes in AML Patients Undergoing Allogeneic Hematopoietic Cell Transplant with Fludarabine/Melphalan-Conditioning with Tacrolimus/Sirolimus-Based Gvhd Prophylaxis
Authors: Amandeep Salhotra, Monzr M. Al Malki, Dongyun Yang, Sally Mokhtari, Ibrahim Aldoss, Ahmed Aribi, Idoroenyi Amanam, Haris Ali, Karamjeet S. Sandhu, Vaibhav Agrawal, Paul B. Koller, Brian J. Ball, Shukaib Arslan, Salman Otoukesh, Amanda Blackmon, Hoda Pourhassan, Yazeed Samara, Tamer Othman, Pamela S. Becker, Vinod Pullarkat, Ricardo Spielberger, Forest Marc Stewart, Eileen Patricia Smith, Andrew Artz, Stephen J. Forman, Guido Marcucci, Anthony Stein, Ryotaro Nakamura
Journal: Blood (2023)
Regulation of Metabolic Homeostasis By TRAF6 Contributes to the Leukemia Progression
Authors: Shinichiro Matsui, Chihiro Ri, Lyndsey C. Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Koutaro Yokote, Daniel T. Starczynowski, Emiko Sakaida, Tomoya Muto
Journal: Blood (2023)
Venetoclax in Combination with Intermediate Doses of Cytarabine in Consolidation Phase for Acute Myeloid Leukemia Patients in First Complete Remission; Results of the Part 1 of the Phase 1/2 Multicentric Covenidac Study
Authors: Lauris Gastaud, Pierre Peterlin, Mathilde Hunault, Emmanuel Raffoux, Sarah Bertoli, Martin Carré, Cecile Pautas, Sylvain Chantepie, Juliette Lambert, Nicolas Duployez, Karine Celli-Lebras, Ariane Mineur, Claude Gardin, Norbert Vey, Arnaud Pigneux, Eric Delabesse, Claude Preudhomme, Adriana Plesa, Francois Vergez, Jean-François Hamel, Herve Dombret, Christian Recher
Journal: Blood (2023)
Haploidentical Hematopoietic Cell Transplantation Combined with an Unrelated Cord Blood Unit for Adult Acute Myeloid Leukemia Results in Improved Survival Compared to Haploidentical Hematopoietic Cell Transplantation: Results of a Multicenter, Randomized, Phase III Trial
Authors: Biqi Zhou, Jia Chen, Tianhui Liu, Yanming Zhang, Yishan Ye, Yiyang Ding, Mingqing Zhu, Xiao Ma, Xiaoli Li, Zhihong Lin, He Huang, Yang Xu, Depei Wu
Journal: Blood (2023)
Safety and Financial Analysis of Outpatient Hypercvad Arm a Administration for Acute Lymphoblastic Leukemia
Authors: Yujiao Sun, Ariel Denson, Katherine Tobon, Rebecca Jean Nelson, Amber Lubas, Bijal D. Shah, Timothy Kubal, Christopher Rodriguez Salamanca, Jad Chahoud, Javier Pinilla-Ibarz, Leidy Lismeris Isenalumhe
Journal: Blood (2023)
<i>Nlrc3</i> Signaling Is Indispensable for Hematopoietic Stem Cell Emergence Via Notch Signaling in Vertebrates
Authors: Shuyang Cai, Honghu Li, Ruxiu Tie, Wei Shan, Qian Luo, Shufen Wang, Huiqiao Chen, Meng Zhang, Xu Yulin, Jiahui Lu, Pengxu Qian, He Huang
Journal: Blood (2023)
Durable Outcomes with Manageable Safety Leading to Prolonged Survival with Tagraxofusp for Treatment-Naive Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: Updated Results from a European Named Patient Program
Authors: Emanuele Angelucci, Eric Deconinck, David Manteigas, Michael Zuurman, Marco Herling
Journal: Blood (2023)
Validation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) Who Underwent Allogenic Stem Cell Transplantation (HSCT)
Authors: Tariq Kewan, Jan Philipp Bewersdorf, Ondrej Blaha, Maximilian Stahl, Najla H Al Ali, Amy E. DeZern, Mikkael A. Sekeres, Geoffrey L Uy, Hetty E. Carraway, Pinkal Desai, Elizabeth A. Griffiths, Eytan M. Stein, Andrew M. Brunner, Maria L Amaya, Joshua F. Zeidner, Michael R. Savona, Jessica M. Stempel, Namrata Sonia Chandhok, Constantine Logothetis, Hunter Cochran, Ameera Rose, Gail J. Roboz, Eunice S. Wang, Benjamin Rolles, Amyah C. Harris, Rory M. Shallis, Zhuoer Xie, Eric Padron, Jaroslaw P. Maciejewski, David A Sallman, Matteo Giovanni Della Porta, Rami S. Komrokji, Amer M. Zeidan
Journal: Blood (2023)
BCOR Loss Confers Increased Stemness and Partially Rescues RUNX1-Deficient Phenotypes in Human Hematopoietic Stem and Progenitor Cells
Authors: Kendra K Jackson, Amy C Fan, Daiki Karigane, Feifei Zhao, Cailin T Collins, Yusuke Nakauchi, Kensuke Kayamori, Athreya S Rangavajhula, Thomas Koehnke, Ravindra Majeti
Journal: Blood (2023)
Phase 1b/2 Study of Escalating Doses of the NEDD8 Activating Enzyme Inhibitor Pevonedistat Administered in Combination with Standard Induction Therapy (Cytarabine and Idarubicin) in Newly Diagnosed High Risk Acute Myeloid Leukemia
Authors: Carissa M. Feliciano, Jennifer S. Carew, Hetty E. Carraway, Justin M. Watts, Sharad Khurana, Bhumika J. Patel, Keri Maher, Claudia Espitia, Kaijin Wu, Denice Tsao-Wie, Xuelian Chen, Mikkael A. Sekeres, Stan Louie, Homa Dadrastoussi, Eduardo Fernandez, Julian Olea, Brandon Sookdeo, Steffan T. Nawrocki, George Yaghmour, Kevin R. Kelly
Journal: Blood (2023)
Trametinib Maintenance in Patients with RAS Mutated Hematologic Malignancy Undergoing Allogeneic Haematopoietic Stem-Cell Transplantation: A Retrospective Transplant Study
Authors: Zhihui Li, Teng Xu, Xianxuan Wang, Xiaopei Wen, Lei Wang, Jingjing Wang, Tong Wu
Journal: Blood (2023)
Engineering Sequential Mutations into Human HSPCs Yields an Aggressive Myeloid Malignancy Allowing for Interrogation of Preleukemic Transformation
Authors: Cailin T Collins, Yusuke Nakauchi, Thomas Koehnke, James S Chavez, Suyoun Choi, Rajiv Sharma, Feifei Zhao, Ravindra Majeti
Journal: Blood (2023)
Racial Disparities in Hospital Outcomes of Autologous Stem Cell Transplantation for Multiple Myeloma: A Comparative NIS 2016 to 2020 Database Study
Authors: Niraj Neupane, Arnav Srivastava, Aditya Sanjeevi, Shubham Agrawal, Amir Mahmoud, Anish Shah, Pravash Budhathoki, Himal Kharel, Utsav Joshi, Binod Dhakal
Journal: Blood (2023)
Potent <i>in Vitro</i> and <i>In Vivo</i> Efficacy of BYON4413, a Duba-Based Antibody-Drug Conjugate Targeting CD123 in Acute Myeloid Leukemia
Authors: Miranda van der Lee, Tanja van Achtenberg, Annet Brouwers-Vos, Monique van der Vleuten, Wendy Kappers, Gijs Verheijden, Geert A. Huls, Glenn van Wigcheren, Ruud Ubink, Aloys Sesink, Alyson MacInnes, Jan Jacob Schuringa, Wim Dokter
Journal: Blood (2023)
Health-Related Quality of Life and Symptom Burden Profile of Patients with Pre-Fibrotic and Overt Myelofibrosis: A Preliminary Report from the Gimema-Prophecy Observational Study
Authors: Giovanni Caocci, Francesca Palandri, Giuseppe Gaetano Loscocco, Alessia Tieghi, Andrea Patriarca, Alessandra Iurlo, Elisabetta Abruzzese, Elena Rossi, Thomas Baldi, Carmen Fava, Eloise Beggiato, Simona Tomasetti, Monia Marchetti, Daniele Vanni, Claudio Fozza, Mario Luppi, Giorgio La Nasa, Paola Fazi, Marco Vignetti, Alessandro Maria Vannucchi, Fabio Efficace
Journal: Blood (2023)
A Novel PI3K γ/δ and DNA-PK Triple Inhibitor, BR101801, for r/r PTCL: A Phase 1a/b, Multi-Center, Open-Label Clinical Trial
Authors: Bong-Seog Kim, Seok Jin Kim, Dok Hyun Yoon, Jin Seok Kim, Tae Min Kim, Eunyoung Lee, Jeong-Ok Lee, Deok-Hwan Yang, Won-Sik Lee
Journal: Blood (2023)
Biological and Clinical Significance of Undetectable Circulating Tumor Cells (CTCs) in Patients (Pts) with Multiple Myeloma (MM)
Authors: Juan-José Garcés, Rosalinda Termini, Esperanza Martín-Sánchez, Marta Lasa, Jose J Perez, Norma C. Gutierrez, Manuela Fernández, Maria Jose Calasanz, Laura Rosiñol, Miguel Teodoro Hernández Garcia, Albert Oriol, Anna Maria Sureda Balari, Albert Perez Montaña, Enrique M Ocio, Maria Casanova Espinosa, Felipe Prosper, Joaquin Martinez-Lopez, Jorge Labrador, Esther Gonzalez Garcia, Rafael Ríos, Fernando Escalante, Joan Bargay, Elena Cabezudo, Valentín Cabañas, Niels Weinhold, Aldo Roccaro, Herve Avet-Loiseau, Alberto Orfao, Joan Blade Creixenti, Maria Victoria Mateos, Juan Jose Lahuerta Palacios, Jesus San-Miguel, María T Cedena, Noemi Puig, Bruno Paiva
Journal: Blood (2023)
Venetoclax Has Potent Efficacy in <i>NPM1</i> mutated AML with Acquired Resistance Associated with Either Perturbed Pro-Survival Signalling or <i>NPM1</i> wild-Type Populations
Authors: Chong Chyn Chua, Natasha Anstee, Christoffer Flensburg, Charis Teh, Adam Ivey, Noorul Amin, Rachel Thijssen, Stefan K. Bohlander, Purvi M. Kakadia, Zhen Xu, Chun Yew Fong, Stephen Ting, Sun Loo, Ing Soo Tiong, Daniel Gray, Shaun Fleming, Nadia Davidson, Andrew W. Roberts, Ian Majewski, Andrew H. Wei, Fiona C. Brown
Journal: Blood (2023)
Impact of Ibrutinib Dose Reduction on Duration of Therapy in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Authors: Mazyar Shadman, Sudeep Karve, Sima Patel, Andrew Rava, Haiyan Sun, Amanda Howarth, Samantha Tomicki, Bhavini P. Srivastava, Deborah M. Stephens
Journal: Blood (2023)
<i>H2-K1</i> on <i>MLL-AF9</i> Leukemia Cells Facilitates the Escape of NK Cell-Mediated Immune Surveillance
Authors: Somadri Ghosh, Maria Rodriguez Zabala, Gladys Telliam Dushime, Katrin Reinbach, Ramprasad Ramakrishnan, Ewa Sitnicka, Marcus Järås
Journal: Blood (2023)
Evaluation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) with Missing Molecular Data
Authors: Tariq Kewan, Jan Philipp Bewersdorf, Ondrej Blaha, Maximilian Stahl, Najla H Al Ali, Amy E. DeZern, Mikkael A. Sekeres, Hetty E. Carraway, Pinkal Desai, Elizabeth A. Griffiths, Eytan M. Stein, Andrew M. Brunner, Maria L Amaya, Joshua F. Zeidner, Michael R. Savona, Jessica M. Stempel, Namrata Sonia Chandhok, Constantine Logothetis, Hunter Cochran, Abhay Singh, Gail J. Roboz, Benjamin Rolles, Eunice S. Wang, Amyah C. Harris, Rory M. Shallis, Zhuoer Xie, Eric Padron, David A Sallman, Jaroslaw P. Maciejewski, Matteo Giovanni Della Porta, Rami S. Komrokji, Amer M. Zeidan
Journal: Blood (2023)
Acute Inflammation Redirect Bone Marrow Hematopoietic Stem Cell Cycling and Differentiation Program By Reshaping Their Chromatin Architecture at Long-Term
Authors: Greta Zara, Amy Leung, Hiroyuki Kato, Dustin Schones, Young-Woong Kim, Sonia Rodriguez-Rodriguez, Huajia Zhang, Zhaohui Gu, Nadia Carlesso
Journal: Blood (2023)
Combining PET/CT and Ctdna Assessments at 6 Months from Induction Treatment Better Predicts Outcome in Previously Untreated Patients with Follicular Lymphoma: A Relevance Ancillary Lysa Study
Authors: Alexis Claudel, Anne Ségolène Cottereau, Emmanuel Bachy, Pierre Feugier, Rene-Olivier Casasnovas, Corinne Haioun, Herve Tilly, Nicolas Daguindau, Guillaume Cartron, Emmanuelle Nicolas Virelizier, Pauline Brice, Benoit Tessoulin, Christophe Fruchart, Sylvie Glaisner, Alain Jacques Delmer, Emmanuel Fleck, Gian Matteo Pica, Hacene Zerazhi, Stephanie Guidez, Morgane Cheminant, Luc Xerri, Laetitia Vercellino, Loïc Chartier, Lucie Gomes, Pierre-Julien Viailly, Marie-Helene Delfau, Franck Morschhauser
Journal: Blood (2023)
RAMP up: Risk Adapted Post-Autologous Transplant Maintenance Therapy in MRD Positive Myeloma Patients
Authors: Karen Sweiss, Craig C. Hofmeister, Ghulam Rehman Mohyuddin, Amandeep Godara, Brian McClune, Damiano Rondelli, Danny Hadidi, David Chan, Matias Eugenio Sanchez, Min Hai, Mitch A. Phelps, Chukwuemeka Uzoka, Douglas Sborov
Journal: Blood (2023)
Real-World Outcomes Following Dose Modifications of First-Line Ibrutinib in Patients with Waldenström Macroglobulinemia
Authors: Shayna R Sarosiek, Gottfried R. von Keudell, Jonas Paludo, Monika Salkar, Barnabie Agatep, Anjali Franco, Samuel Crawford, Michelle Pacia, Jorge J. Castillo
Journal: Blood (2023)
Unraveling Pathophysiology and Hematopoiesis of Vexas Syndrome By Multi-Omics Analyses and Targeted Gene Editing
Authors: Raffaella Molteni, Martina Fiumara, Corrado Campochiaro, Alessandro Tomelleri, Elisa Diral, Angelica Varesi, Alessandra Weber, Davide Stefanoni, Roberta Alfieri, Luisa Albano, Maddalena Panigada, Eleonora Cantoni, Daniele Canarutto, Luca Basso-Ricci, Pamela Quaranta, Angelo D'Alessandro, Marco Matucci-Cerinic, Raffaella Di Micco, Serena Scala, Alessandro Aiuti, Fabio Ciceri, Ivan Merelli, Lorenzo Dagna, Simone Cenci, Giulio Cavalli, Luigi Naldini, Samuele Ferrari
Journal: Blood (2023)
Prognostic Impact of Skeletal Muscle Index and Vitamin D in Diffuse Large B-Cell Lymphoma
Authors: Nobuhiko Nakamura, Nobuhiro Kanemura, Ryoma Shimazu, Takayuki Goto, Yuto Kaneda, Yoshikazu Ikoma, Takuro Matsumoto, Hiroshi Nakamura, Masahito Shimizu
Journal: Blood (2023)
Validation of a Composite Real-World Mortality Variable Among Patients with Hematologic Malignancies Treated in the United States
Authors: Sharlene Dong, Ankit J. Kansagra, Gurbakhash Kaur, Anna Barcellos, Andrew J. Belli, Laura L. Fernandes, Eric Hansen, Jacob Ambrose, Claire Bai, Christina M. Zettler, Ching-Kun Wang
Journal: Blood (2023)
HMR Mutations Drive Poor Prognosis in Myelofibrosis Patients with Lower <i>JAK2</i>V617F Allele Burden but Not in Those with Higher Allele Burden: Results of a Multicenter Study
Authors: Yu-Hung Wang, Carmelo Gurnari, Chao-Hung Wei, Hussein Awada, Chien-Chin Lin, Andrius Zucenka, Chi-Yuan Yao, Kristian Gurashi, Hsin-An Hou, Kiran Batta, Wen-Chien Chou, Jaroslaw P. Maciejewski, Daniel H Wiseman, Hwei-Fang Tien
Journal: Blood (2023)
Transcranial Doppler Screening of Children with Sickle Cell Disease for a Large, Multinational Interventional Study: Experience from the Phase 3 HOPE-Kids 2 Trial Investigating the Effect of Voxelotor Treatment on Transcranial Doppler Flow Velocity
Authors: Halima Bello-Manga, Videlis Nduba, Shehu Umar Abdullahi, Jessie Githanga, Bernhards Ogutu, Amal M. El-Beshlawy, Hoda MA Hassab, Mohamed Badr, Azza Tantawy, Biobele J Brown, Vivian Paintsil, Adeseye Michael Akinsete, Catherine I. Segbefia, Iheanyi Okpala, Yasser Wali, Mohammed Essa, Jason Farthing, Jennifer Doss, Sandy Dixon, Clark Brown, Fenella Kirkham
Journal: Blood (2023)
Unrelated Donors below 35 Years of Age Should be Preferred over HLA-Matched Sibling Donors Older Than 50 Years for Patients with Myeloid Malignancies
Authors: Johannes Schetelig, Henning Baldauf, Carina Rave, Gesine Bug, Lutz Peter Hermann Mueller, Eva Wagner Drouet, Francis A. Ayuk, Wolfgang Andreas Bethge, Matthias Stelljes, Thomas Schröder, Desiree Kunadt, Katja Sockel, Jan Moritz Middeke, Daniel Fürst, Alexander H. Schmidt, Katharina Fleischhauer, Martin Bornhäuser
Journal: Blood (2023)
Recurrent Leg Deep Vein Thrombosis in a Female with Atypical Right-Sided Variant of May Thurner Syndrome and Factor V Leiden Mutation
Authors: Krunal Trivedi, Hamid Shaaban, Gunwant Guron, Tapan Thaker, Theresa Aquino, Bader Omour, Murad Qirem
Journal: Blood (2023)